Amarin (AMRN)
(Delayed Data from NSDQ)
$0.87 USD
+0.01 (1.72%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.90 +0.03 (2.87%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Earnings News For AMRN
-
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
-
Amarin: Q4 Earnings Snapshot
-
Amarin: Q4 Earnings Snapshot
-
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Amarin (AMRN) Q3 Earnings and Revenues Surpass Estimates
-
Amarin: Q3 Earnings Snapshot
-
Amarin Reports Third Quarter 2023 Financial Results
-
Amarin (AMRN) Q2 Earnings and Revenues Surpass Estimates
-
Amarin: Q2 Earnings Snapshot
-
Amarin Reports Second Quarter 2023 Financial Results
-
Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall
-
Amarin: Q1 Earnings Snapshot
-
Amarin Reports First Quarter 2023 Financial Results and Provides Business Update
-
Amarin's (AMRN) Q4 Earnings and Revenues Beat Estimates
-
Amarin: Q4 Earnings Snapshot
-
Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
Amarin (AMRN) Q3 Earnings Beat, Sales Hurt by Vascepa Generics
-
Amarin: Q3 Earnings Snapshot
-
Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Amarin (AMRN) Q2 Earnings & Sales Hurt by Vazkepa Generics
-
Amarin: Q2 Earnings Snapshot
-
Amarin Reports Second Quarter 2022 Financial Results and Provides Business Update
-
Amarin (AMRN) Q1 Earnings & Sales Hurt by Vascepa Generics
-
Amarin (AMRN) Q4 Earnings Top, Sales Hurt by Vascepa Generics
-
Amarin (AMRN) Q3 Earnings Top, Vascepa Sales Decline Y/Y